Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.74 |
| ▸ | CTSK | P43235 | 3/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.45 |
| ▸ | NPY4R | P50391 | 6/20 | 0.43 |
| ▸ | NPY1R | P25929 | 4/20 | 0.43 |
| ▸ | NPY2R | P49146 | 3/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.43 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Antipain SCHEMBL18328611 | 1.00 | SMN1; SMN2 (0.74) | SMN1; SMN2CTSKCTSBNPY4RNPY1R | |
| Antipain SCHEMBL14038024 | 1.00 | SMN1; SMN2 (0.74) | SMN1; SMN2CTSKCTSBNPY4RNPY1R | |
| Antipain SCHEMBL3280675 | 1.00 | SMN1; SMN2 (0.74) | SMN1; SMN2CTSKCTSBNPY4RNPY1R | |
| Antipain SCHEMBL5966873 | 1.00 | SMN1; SMN2 (0.74) | SMN1; SMN2CTSKCTSBNPY4RNPY1R | |
| Antipain SCHEMBL642095 | 1.00 | SMN1; SMN2 (0.74) | SMN1; SMN2CTSKCTSBNPY4RNPY1R | |
| SCHEMBL26807763 | 0.97 | SMN1; SMN2 (0.69) | SMN1; SMN2CTSKCTSBNPY4RNPY1R | |
| SCHEMBL17364033 | 0.97 | SMN1; SMN2 (0.69) | SMN1; SMN2CTSKCTSBNPY4RNPY1R | |
| SCHEMBL16328962 | 0.93 | SMN1; SMN2 (0.65) | SMN1; SMN2CTSKCTSBNPY4RNPY1R | |
| SCHEMBL17364037 | 0.93 | SMN1; SMN2 (0.64) | SMN1; SMN2CTSKNPY4RNPY1RNPY2R | |
| SCHEMBL17364024 | 0.93 | SMN1; SMN2 (0.64) | SMN1; SMN2CTSKNPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210088504-A1 | PROTEIN DEGRADATION INDUCING TAG AND USAGE THEREOF | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2021-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210088504-A1 | PROTEIN DEGRADATION INDUCING TAG AND USAGE THEREOF | SENP8, SENP6, SENP7 | SMN1; SMN2 4697/4885CTSK 914/4885CTSB 624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.